Newsroom
Spotlight Story
Decades of Dedication: UCB’s Ongoing Commitment to Epilepsy through the Family Epilepsy Scholarship Program™
Read more
Press Releases
BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained…
Read More
Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut…
Read More
Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t…
Read More
BIMZELX® (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed…
Read More
BIMZELX® (bimekizumab-bkzx) Data in Moderate-to-Severe Plaque Psoriasis at EADV Showed Complete…
Read More
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for…
Read MoreUCB Stories
Multidisciplinary Collaboration as the Future of Patient-Centered Care
Read More
Innovative Collaborations: Enhancing Epilepsy Care through UCB and Morehouse's Community-Based…
Read More
From Bandages to Bravery: HS Patients Command Times Square in Unforgettable Event
Read More
Gen Z and Millennial Patients Find “Rheum for Improvement” in Disease Management
Read More
The profound impact on the lives of people living with thymidine kinase 2 deficiency (TK2d)
Read More
